5-Fluorouracil: mechanisms of action and clinical strategies

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Nature Reviews. Cancer

• Publication date

  2003-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nrc1074PMID 12724731
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biochemical effects of folate-based inhibitors of thymidylate synthase in MGH-U1 cells

  2004cited by this paper
• Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy-5-fluorouridine

  2004cited by this paper
• The inhibitory effects of 5-fluorouracil on the metabolism of preribosomal and ribosomal RNA in L-1210 cells in vitro

  2004cited by this paper
• Identification of 5-fluorouracil-inducible target genes using cDNA microarray profiling.

  2003cited by this paper
• Profound dihydropyrimidine dehydrogenase deficiency resulting from a novel compound heterozygote genotype.

  2002cited by this paper
• P53 overexpression predicts poor chemosensitivity to high‐dose 5‐fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection

  2002cited by this paper
• DNA mismatch repair defects: role in colorectal carcinogenesis.

  2002cited by this paper
• Uridine phosphorylase (-/-) murine embryonic stem cells clarify the key role of this enzyme in the regulation of the pyrimidine salvage pathway and in the activation of fluoropyrimidines.

  2002cited by this paper
• Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer.

  2002cited by this paper
• Genome-wide cDNA microarray screening to correlate gene expression profiles with sensitivity of 85 human cancer xenografts to anticancer drugs.

  2002cited by this paper
• The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.

  2002cited by this paper
• Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.

  2001cited by this paper
• Thymidylate synthase pharmacogenetics in colorectal cancer.

  2001cited by this paper
• Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses.

  2001cited by this paper
• Topoisomerase-1 (topo-I) and thymidylate synthase (TS) primary tumor expression as prognostic and predictive factors for response to cpt-11 in advanced colorectal cancer (crc) patients

  2001cited by this paper
• Polymorphism in the thymidylate synthase promoter enhancer region in colorectal cancer.

  2001cited by this paper
• Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy

  2001cited by this paper
• Pharmacogenomic dissection of resistance to thymidylate synthase inhibitors.

  2001cited by this paper
• Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study.

  2001cited by this paper
• Capecitabine: a novel agent for the treatment of solid tumors

  2001cited by this paper
• The role of dUTPase and uracil-DNA repair in cancer chemotherapy.

  2001cited by this paper
• Retroviral transduction of human dihydropyrimidine dehydrogenase cDNA confers resistance to 5-fluorouracil in murine hematopoietic progenitor cells and human CD34+-enriched peripheral blood progenitor cells

  2001cited by this paper
• P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma.

  2001cited by this paper
• Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles.

  2001cited by this paper
• Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer.

  2000cited by this paper
• Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group.

  2000cited by this paper
• A gene expression database for the molecular pharmacology of cancer

  2000cited by this paper
• p21(WAF1/Cip1): more than a break to the cell cycle?

  2000cited by this paper
• Deoxyuridine triphosphatase (dUTPase) expression and sensitivity to the thymidylate synthase (TS) inhibitorD9331

  2000cited by this paper
• Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.

  2000influential reference
• Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial.

  2000cited by this paper
• Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients

  2000cited by this paper
• Role of BAX in the apoptotic response to anticancer agents.

  2000cited by this paper
• Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients

  2000cited by this paper
• p53 dependence of Fas induction and acute apoptosis in response to 5-fluorouracil-leucovorin in human colon carcinoma cell lines.

  2000cited by this paper
• Life-threatening toxicity in a dihydropyrimidine dehydrogenase-deficient patient after treatment with topical 5-fluorouracil.

  1999cited by this paper
• Disruption of p53 in human cancer cells alters the responses to therapeutic agents.

  1999cited by this paper
• Increased cytotoxicity and bystander effect of 5-fluorouracil and 5′-deoxy-5-fluorouridine in human colorectal cancer cells transfected with thymidine phosphorylase

  1999cited by this paper
• Fas ligand-induced apoptosis.

  1999cited by this paper
• Microsatellite instability in human cancer: a prognostic marker for chemotherapy?

  1999cited by this paper
• Clinical Pharmacology and Resistance to Dihydrofolate Reductase Inhibitors

  1999cited by this paper
• A review of the pharmacology and clinical activity of new chemotherapy agents for the treatment of colorectal cancer.

  1999cited by this paper
• Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers.

  1999cited by this paper
• Tumor Suppressor p53 Can Participate in Transcriptional Induction of the GADD45 Promoter in the Absence of Direct DNA Binding

  1998cited by this paper
• Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.

  1998cited by this paper
• High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with nonresponse to 5-fluorouracil.

  1998cited by this paper
• Oxaliplatin: mechanism of action and antineoplastic activity.

  1998cited by this paper
• Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer.

  1998cited by this paper
• Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National Surgical Adjuvant Breast and Bowel Project protocol C-05.

  1998cited by this paper
• Topoisomerase-I inhibitor SN-38 can induce DNA damage and chromosomal aberrations independent from DNA synthesis.

  1998cited by this paper
• Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue.

  1998cited by this paper
• p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survival.

  1998cited by this paper
• Thymineless death in colon carcinoma cells is mediated via fas signaling.

  1997cited by this paper
• The fas signaling pathway is functional in colon carcinoma cells and induces apoptosis.

  1997cited by this paper
• Immunohistochemical determination of thymidylate synthase in colorectal cancer--methodological studies.

  1997cited by this paper
• Phase III randomized study to compare interferon alfa-2a in combination with fluorouracil versus fluorouracil alone in patients with advanced colorectal cancer.

  1996cited by this paper
• Antitumor activity and low intestinal toxicity of S-1, a new formulation of oral tegafur, in experimental tumor models in rats

  1996cited by this paper
• Re: the p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry.

  1996cited by this paper
• Randomized trial assessing the addition of interferon alpha-2a to fluorouracil and leucovorin in advanced colorectal cancer. Colorectal Cancer Working Party of the United Kingdom Medical Research Council.

  1996cited by this paper
• Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma.

  1996cited by this paper
• Immunoreactive dUMP and TTP pools as an index of thymidylate synthase inhibition; effect of tomudex (ZD1694) and a nonpolyglutamated quinazoline antifolate (CB30900) in L1210 mouse leukaemia cells.

  1996cited by this paper
• The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry.

  1996cited by this paper
• Analysis of mismatch repair genes in hereditary non–polyposis colorectal cancer patients

  1996cited by this paper
• Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5'-terminal regulatory region of the human gene for thymidylate synthase.

  1995cited by this paper
• Attenuation of the antitumor activity of 5-fluorouracil by (R)-5-fluoro-5,6-dihydrouracil.

  1995cited by this paper
• Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil.

  1995cited by this paper
• Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators.

  1995cited by this paper
• Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors.

  1995cited by this paper
• Efficacy of adjuvant fluorouracil and folinic acid in colon cancer

  1995cited by this paper
• Ratio of 2'-deoxyadenosine-5'-triphosphate/thymidine-5'-triphosphate influences the commitment of human colon carcinoma cells to thymineless death.

  1995cited by this paper
• Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. Advanced Colorectal Cancer Meta-Analysis Project.

  1994cited by this paper
• Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.

  1994cited by this paper
• Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer

  1994cited by this paper
• Identification of a thymidylate synthase ribonucleoprotein complex in human colon cancer cells

  1994cited by this paper
• Specific inhibition of pre-ribosomal RNA processing in extracts from the lymphosarcoma cells treated with 5-fluorouracil.

  1994cited by this paper
• Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma.

  1993cited by this paper
• Cytokines Induce Uridine Phosphorylase in Mouse Colon 26 Carcinoma Cells and Make the Cells More Susceptible to 5′‐Deoxy‐5‐fluorouridine

  1993cited by this paper
• A Southwest Oncology Group study

  1993cited by this paper
• Ribonucleoprotein particle assembly and modification of U2 small nuclear RNA containing 5-fluorouridine.

  1993cited by this paper
• Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells.

  1993cited by this paper
• Phase II study of fluorouracil, leucovorin, and interferon alfa-2a in metastatic colorectal carcinoma.

  1993cited by this paper
• Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma.

  1993cited by this paper
• Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.

  1992cited by this paper
• Enhanced 5-fluorouracil cytotoxicity and elevated 5-fluoronucleotides in the rat Walker carcinosarcoma following methotrexate pre-treatment: a 19F-MRS study in vivo.

  1992cited by this paper
• Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines.

  1992cited by this paper
• Cancer. p53, guardian of the genome.

  1992cited by this paper
• p53, guardian of the genome

  1992cited by this paper
• Mechanism-based inactivation of dihydropyrimidine dehydrogenase by 5-ethynyluracil.

  1992cited by this paper
• Phase II trial of fluorouracil and recombinant interferon alfa-2a in patients with advanced colorectal carcinoma: an Eastern Cooperative Oncology Group study.

  1991cited by this paper
• Interactions of transfer RNA pseudouridine synthases with RNAs substituted with fluorouracil.

  1991cited by this paper
• Role for cytosolic folate-binding proteins in the compartmentation of endogenous tetrahydrofolates and the 5-formyl tetrahydrofolate-mediated enhancement of 5-fluoro-2'-deoxyuridine antitumor activity in vitro.

  1990cited by this paper
• Effect of polyglutamylation of 5,10-methylenetetrahydrofolate on the binding of 5-fluoro-2'-deoxyuridylate to thymidylate synthase purified from a human colon adenocarcinoma xenograft.

  1989cited by this paper
• Clinical Pharmacology of 5-Fluorouracil

  1989cited by this paper
• Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer.

  1989cited by this paper
• Enhancement of 5-fluorouracil's anticancer activity by dipyridamole.

  1989cited by this paper
• Inhibition by methotrexate of the stable incorporation of 5-fluorouracil into murine bone marrow DNA.

  1989cited by this paper
• Selective expansion of 5,10-methylenetetrahydrofolate pools and modulation of 5-fluorouracil antitumor activity by leucovorin in vivo.

  1989cited by this paper
• In vivo potentiation of 5-fluorouracil by leucovorin in murine colon carcinoma.

  1988cited by this paper
• Enhancement of fluorinated pyrimidine-induced cytotoxicity by leucovorin in human colorectal carcinoma cell lines.

  1988cited by this paper
• 5-Fluorouracil substitution alters pre-mRNA splicing in vitro.

  1988cited by this paper

• Nanostructured Lipid Carrier (NLCs): Next Generation Lipid Nanocarriers for Breast Cancer Therapy

  2026cites this paper
• Design, synthesis, and antiproliferative evaluation of dihydropyrimidinone-pyrazole derivatives as potential SHP2 inhibitors via in silico target prediction.

  2026cites this paper
• TBKBP1 induces capecitabine resistance through negative regulation of type I interferon pathway in triple-negative breast cancer

  2026cites this paper
• MCM10, a novel YAP1/TEAD4 target, drives gastric cancer progression by bridging DNA replication to stemness acquisition.

  2026cites this paper
• Design, synthesis and antibacterial evaluation of piperazine urea-pyrazole-pyrimidine hybrids: in-vitro and in-silico studies.

  2026cites this paper
• Metabolic Reprogramming and Therapeutic Vulnerabilities in the Tumor Microenvironment Revealed by Multi-scale Network Geometry

  2026cites this paper
• Antitumor and in vivo antioxidant activity of 24-nor-olean-3-one-28-oic acid isolated from the roots of momordica cymbalaria (hook. F.) fenzl ex naudin in Ehrlich ascites carcinoma transplanted mice.

  2026cites this paper
• The mTORC2 component SIN1 post-transcriptionally regulates TYMS levels and modulates P53 activity in response to 5-FU chemotherapy

  2026cites this paper
• A multifunctional 5-fluorouracil prodrug: synthesis, biological evaluation, and antitumor mechanism investigation.

  2026cites this paper
• Chitosan-functionalized Cu-doped NiO/reduced graphene oxide nanocarrier for pH-triggered delivery of 5-fluorouracil in breast cancer cells.

  2026cites this paper
• Green synthesis, structural, spectroscopic, DFT and anticancer analysis of 5-fluoro-1,2,3,4-tetrahydro pyrimidine-2,4-dione 4-hydroxy-3,5-dimethoxybenzoic acid cocrystal

  2026cites this paper
• Multi-omics characterization of C4orf19 in HNSCC: constructing prognostic signatures for immunotherapy and chemotherapy response prediction

  2026cites this paper
• Quality control and signaling pathways at stalled ribosomes

  2026cites this paper
• Rapid and pump-free generation of static droplet arrays with controllable concentration gradients

  2026cites this paper
• Expanding the Therapeutic Potential of NUIG4: A Multifunctional Metal–Organic Framework for Dual Anticancer and Antibacterial Drug Delivery

  2026cites this paper
• Injectable hydrogel enabled by strained disulfide-thiol exchange and core-shell thiolated copolymer nanoparticles for efficient hydrophobic drug delivery

  2026cites this paper
• Sonoran propolis induces a pro-apoptotic effect through mitotic arrest: a distinct cell cycle outcome compared with its main plant source, Populus fremontii.

  2026cites this paper
• A facile and green synthesis of methyl 7-aryl-5-methyl-4,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate derivatives using hyamine in aqueous media at room temperature

  2026cites this paper
• Artificial intelligence driven multi-omics framework identifies COL6A3 as a diagnostic biomarker and a putative gene target modulated by Embelin in Colorectal cancer

  2026cites this paper
• Transcriptional activation of LINGO1 facilitates proliferation and immune escape in colorectal cancer.

  2026cites this paper
• Advances in vesicular nanocarrier-mediated therapies for hypertrophic scars: mechanistic insights, preclinical evidence and clinical perspectives.

  2026cites this paper
• Identification of TgENT1 as the TgUUT1 Uracil/Uridine Transporter of Toxoplasma gondii

  2026cites this paper
• Novel Active Homo-Aza (Lactam) Steroidal Antimetabolites for the Treatment of Human Pancreatic and Colorectal Cancer.

  2026cites this paper
• Repurposing amide-based drugs unveils inhibition mechanisms of plasmodium falciparum Plasmepsin V enzymatic activity for antimalarial therapy.

  2026cites this paper
• Panobinostat Potentiates the Antitumor Efficacy of 5-Fluorouracil in Gastric Cancer by Suppressing Thymidylate Synthase Expression

  2026cites this paper
• Chemoprevention in Skin Cancer: What Advice?

  2026cites this paper
• Compound 7 h exerts its anti-oncogenic effects on colorectal cancer cells by inducing death-receptor-mediated apoptosis, promoting DNA damage, and obstructing autophagic flux

  2026cites this paper
• Exploring pH‐Responsive Encapsulation and Release of 5‐Fluorouracil Molecules From Yoctowell Cavities

  2026cites this paper
• Fungal commensal promotes intestinal repair via its secreted peptide in mice

  2026cites this paper
• A Framework for Autonomous AI-Driven Drug Discovery

  2026cites this paper
• A tumor spheroid array chip for high-fidelity evaluation of liposomal drug delivery through the EPR effect.

  2026cites this paper
• SOX4-STAT6-MTHFD2 axis drives hepatocellular carcinoma progression and treatment resistance

  2026cites this paper
• A fully validated HPLC-UV detection method associated with color variation control for the evaluation of the long term stability of calcium levofolinate solutions in polyolefin infusion bags and in polypropylene syringes in dose banding conditions.

  2026cites this paper
• Exosomal microRNA profiling reveals candidate biomarkers and regulatory signatures associated with paratuberculosis disease status in goats.

  2026cites this paper
• Bridging mechanism and design: modern medicinal chemistry approaches to thymidylate synthase inhibitors

  2026cites this paper
• Radioligand Therapy in Meningiomas: Today’s Evidence, Tomorrow’s Possibilities

  2026cites this paper
• Ribosome biogenesis rate, a parameter of sensitivity to chemotherapeutic drugs inhibiting rRNA synthesis

  2026cites this paper
• Revealing CASQ1 as a potential target for oral squamous cell carcinoma through gene expression and functional analysis: an in silico approach

  2026cites this paper
• Roles of base and nucleotide excision repair activities in cancer treatment: implications for prognosis and resistance to therapy in breast and colorectal cancers.

  2026cites this paper
• Cell Line–Dependent Cell Death Pathways Induced by Thymoquinone in Colorectal Cancer Cells

  2026cites this paper
• Group-based learning on label-free phase-contrast images across dose and exposure time improves bioactive compound classification

  2026cites this paper
• Pyrimidine nucleoside analogues and antitumour drugs based on them: fifty years in therapy

  2026cites this paper
• Antiviral Profiling and Cellular Activation of Carbobicyclic Nucleoside Analogues.

  2026cites this paper
• Host–Guest Interaction in Zr Metal–Organic Frameworks with a Hydrophilic Site for Drug Delivery

  2026cites this paper
• L-Glutamine attenuates peritoneal fibrosis developed in 5-Fluorouracil-treated mice

  2026cites this paper
• Contextual Invertible World Models: A Neuro-Symbolic Agentic Framework for Colorectal Cancer Drug Response

  2026cites this paper
• In vivo performance of 5-fluorouracil encapsulated on bacterial nanocellulose in an azoxymethane-dextran sulphate sodium induced colorectal cancer: Drug release profiles, histological and biomarkers analysis.

  2026cites this paper
• Enhancing 5-fluorouracil efficacy in colorectal cancer by inhibiting glutathione antioxidant mechanisms with an xCT inhibitor.

  2026cites this paper
• Mebendazole impairs the expression and function of enzymes in nucleotide metabolism pathways, leading to Selective Cytotoxicity, Cell Cycle Arrest, and Damage to Cell Morphology in Gastric Cancer.

  2026cites this paper
• FOXM1 induces therapy resistance and inhibits apoptosis in a variety of human cancers

  2026influential citation
• 5-Fluorouracil-induced intestinal mucositis: Pathogenesis and potential therapeutic interventions.

  2026cites this paper
• Naringenin Alleviates 5-Fluorouracil-Induced Intestinal Mucositis via Modulating the Gut Microbiota, Bile Acid Metabolism, and PPAR Signaling Pathway.

  2026cites this paper
• Tunable PEGylated albumin nanocarriers enhance 5-FU cytotoxic selectivity and modulate oxidative and immune stress in colorectal cancer model.

  2026cites this paper
• Microbiota in pancreatic ductal adenocarcinoma progression and therapy: The hidden players.

  2026cites this paper
• Construction of in situ temperature-sensitive gel of Tegafur derivative TAK5399 and its evaluation against breast cancer.

  2026cites this paper
• Gut microbiota metabolites positively impacts chemotherapy effects in colorectal cancer

  2026cites this paper
• The β-lactam adjuvant guanosine potentiates anti-folate antibiotics and pyrimidine synthesis inhibitors by depleting thymidine in methicillin-resistant Staphylococcus aureus

  2026cites this paper
• Multi-omics analysis and experimental verification reveal the role of dihydrocaffeic acid against 5-fluorouracil-induced intestinal mucositis.

  2026cites this paper
• Fluorine in Pharmaceuticals and Synthetic Strategies for Fluorine-Containing Molecules in Anticancer Drug Discovery: A Review

  2026cites this paper
• Hydrogel Nanoparticles of Retinol Acetate via Modified Rapid Expansion of Supercritical Solution: Design, Optimization, and Anticancer Evaluation.

  2026cites this paper
• MLKL depletion enhances chemotherapy-induced apoptosis in colorectal cancer by prolonged retention of TNFR-I in endosomes

  2026cites this paper
• "Integrative Oncology: Uniting Herbal and Allopathic Medicine for Cancer Management"

  2025cites this paper
• A critical review on the sustainable synthesis of pyrimidine-based heterocycles and their biological activities

  2025cites this paper
• Ameliorative effect of "intestinal-vaginal" probiotics on 5-fluorouracil-induced microbial dysbiosis in colorectal cancer.

  2025cites this paper
• Balance of care activity after EMA recommendation for DPYD gene testing in Galicia

  2025cites this paper
• Phenotypic dominance emerges from activity-fitness functions and molecular interactions

  2025cites this paper
• Some unanswered questions about the pyrimidine catabolic pathway: The human macrophage perspective.

  2025cites this paper
• Astaxanthin Mitigates 5-Fluorouracil-Induced Hepatotoxicity and Oxidative Stress in Male Rats

  2025influential citation
• Drug-Derived Carbon Dots with Red Light Emission and Low Side Effects for Targeting Fluorescence Imaging and Potential Treatment of Liver Cancer

  2025cites this paper
• Targeted Tumor Microenvironment Delivery of Floxuridine Prodrug via Soluble Silica Nanoparticles in Malignant Melanoma as a Model for Aggressive Cancer Treatment

  2025cites this paper
• TIMP‐2 Modulates 5‐Fu Resistance in Colorectal Cancer Through Regulating JAK–STAT Signalling Pathway

  2025cites this paper
• The synergistic antitumour effect of Carrimycin combined with 5-fluorouracil on colorectal cancer

  2025cites this paper
• Calcite nano-structure as a novel drug carrier for 5-Fluorouracil chemotherapy agent: A computational study using DFT and AIMD

  2025cites this paper
• Reducing Dietary Protein Enhances the Antitumor Effects of Chemotherapy through Immune-Mediated Mechanisms

  2025cites this paper
• IFNα2b/5-FU inhibits proliferation and cell cycle of squamous carcinoma cell line Cal27.

  2025cites this paper
• A Rapid Approach for Identifying Cell Lines Lacking Functional Cytidine Deaminase

  2025cites this paper
• KLF6-mediated recruitment of the p300 complex enhances H3K23su and cooperatively upregulates SEMA3C with FOSL2 to drive 5-FU resistance in colon cancer cells

  2025cites this paper
• Targeted Modulation of Mitochondrial Oxidative Stress Ameliorates 5-Fluorouracil-Induced Renal Injury in BALB/c Mice

  2025cites this paper
• Sinomenine synergistically enhances 5-Fu anticancer effects in oral cancer through modulating the miR-140-5p-PDK1-anaerobic glycolysis pathway.

  2025cites this paper
• TF-chRDP: a method for simultaneously capturing transcription factor binding chromatin-associated RNA, DNA and protein

  2025cites this paper
• Zeolites and zeolite imidazole frameworks in pharmacy (review)

  2025cites this paper
• 5'-S-(3-aminophenyl)-5'-thioadenosine, a novel chemoprotective agent for reducing toxic side effects of fluorouracil in treatment of MTAP-deficient cancers.

  2025cites this paper
• The Impact of Polyunsaturated Fatty Acids in Cancer and Therapeutic Strategies

  2025cites this paper
• Multi-omics analysis of endothelial cells reveals the metabolic diversity that underlies endothelial cell functions

  2025cites this paper
• Update in the Diagnosis and Management of Ocular Surface Squamous Neoplasia (OSSN)

  2025cites this paper
• Advances in Targeted and Chemotherapeutic Strategies for Colorectal Cancer: Current Insights and Future Directions

  2025cites this paper
• A bacterial genotoxin reveals a p53-proteasome-LC3 regulatory axis that drives the suppression of autophagy in cells experiencing sublethal DNA damage

  2025cites this paper
• Natural Alternatives in the Treatment of Colorectal Cancer: A Mechanisms Perspective

  2025cites this paper
• Juniperus indica Bertol Extract Combined with 5-Fluorouracil Synergistically Suppresses the Growth of Esophageal Squamous Cell Carcinoma Cells

  2025cites this paper
• CD44 variant exons induce chemoresistance by modulating cell death pathways

  2025cites this paper
• Recent advances of macroporous hydrogel microparticles: Fabrication and applications

  2025cites this paper
• Trifluridine/tipiracil induces ferroptosis by targeting p53 via the p53-SLC7A11 axis in colorectal cancer 3D organoids

  2025cites this paper
• Pharmacokinetics and bioequivalence of two formulations of the S-1 (tegafur/gimeracil/oxonate) capsule in Chinese cancer patients under fasting and fed conditions: a multicenter, randomized, open-label, single-dose, double-cycle crossover study

  2025cites this paper
• Chemoresistance mechanisms to 5-Fluorouracil and reversal strategies in lung and breast cancer

  2025cites this paper
• Arginine Deprivation Induces Quiescence and Confers Vulnerability to Ferroptosis in Colorectal Cancer

  2025cites this paper
• NAIL-MS reveals tRNA and rRNA hypomodification as a consequence of 5-fluorouracil treatment

  2025cites this paper
• Carmofur Exhibits Antimicrobial Activity Against Streptococcus pneumoniae

  2025cites this paper
• Microglia‐Mediated Synaptic Dysfunction Contributes to Chemotherapy‐Related Cognitive Impairment

  2025cites this paper
• Chromatin structure and gene transcription of recombinant p53 adenovirus vector within host

  2025cites this paper
• Construction of Dynamic Hydrogel Inducing Effective and Selective 5-Fluorouracil Monotherapy against Cervical Cancer Cells

  2025cites this paper